Back to search

United Kingdom· GB-APID-14602911000001103

Torisel 30mg/1.2ml concentrate for solution for infusion vials and diluent

A temsirolimus product containing temsirolimus, registered in United Kingdom by Pfizer Ltd. The same ATC class is registered in 10 of our 19 countries.

ATC L01EG01

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedTorisel 30mg/1.2ml concentrate for so…ATCL01EG01REGISTER NO.GB-APID-1460291100000…PACKS LISTED2CHECKEDSeptember 13, 2026

Where it is registered

Temsirolimus is registered in 10 of 19 countries.

Countries holding a registration under ATC L01EG01 (temsirolimus), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 5 of them publish a price we can compare per daily dose

Temsirolimus · ATC L01EG01

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Japan
  • Netherlands
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Temsirolimus
Manufacturer
Pfizer Ltd
Country
United Kingdom (GB)
ATC code
L01EG01
ATC class
Temsirolimus
Defined daily dose
3.57 mg, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    5010981002868
  • gtin
    5415062368145

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

596 interactions on record for temsirolimus.

Graded by severity as the source publishes them — 168 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Temsirolimus · interactions on record

596 records

  • 168 severe
  • 419 moderate
  • 9 minor

Most severe, free to view

  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • Polymyxin BA07AA05severe
  • Amphotericin BA07AA07severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/01adcec9-b55f-4c85-8cbb-489009903993
GET /v1/drugs/01adcec9-b55f-4c85-8cbb-489009903993?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "14602911000001103",
  "desc": "Torisel 30mg/1.2ml concentrate for solution for infusion vials and diluent (Pfizer Ltd)",
  "form": "Solution for infusion",
  "vpid": "35915411000001108",
  "source": "dmd",
  "vtm_id": "777703008",
  "strength": "25 mg",
  "substance": "Temsirolimus",
  "ingredient": "Temsirolimus",
  "supplier_code": "2082201000001106"
}

See everything about temsirolimus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.